Viewing Study NCT02721732


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2026-02-26 @ 12:38 AM
Study NCT ID: NCT02721732
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-31
First Post: 2016-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
Sponsor:
Organization: